Azopt (BRINZOLAMIDE)
Azopt (BRINZOLAMIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Azopt; Generic name: BRINZOLAMIDE; Drug class: Carbonic Anhydrase Inhibitor [EPC].
| Brand name | Azopt |
|---|---|
| Generic name | BRINZOLAMIDE |
| Drug class | Carbonic Anhydrase Inhibitor [EPC] |
| Manufacturer | Sandoz Inc |
| Used for | 1 INDICATIONS AND USAGE AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. AZOPT is a carbonic anhydrase inhibitor indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION The recommended dose is one drop of AZOPT in the affected eye(s) 3 times daily. Shake well before use. AZOPT may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least 10 minutes apart. • Instill one drop in the affected eye(s) 3 times daily. ( 2 ) • If more than one topical ophthalmic drug is being used, the drugs should be administered at least |
| Active ingredient(s) | BRINZOLAMIDE |
| Route | OPHTHALMIC |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0afb6589-51ba-432c-aed1-20a12d5d3455 |